AbCellera, Vertex partner on next-gen T-cell engagers
Source: BioPharma Dive - Latest News
The deal adds to a growing streak of partnerships involving new types of T cell engagers and gives Vertex another chance to broaden a business still reliant on cystic fibrosis medicines.